Search Results
Jul 23, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Intuit Inc. and Certain Officers - INTU
entitled "Intuit to cut 17% of global jobs to streamline operations, memo shows". Citing an internal Company memorandum and email from Defendant Sasan K. Goodarzi ("Goodarzi"), Intuit's Chairman and Chief Executive Officer, to staff earlier in the day, the article reported that "Intuit . . . is laying
More news about: Pomerantz LLP
Jul 23, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Lucid Group, Inc . and Certain Officers - LCID
over the following two trading sessions, to close at $8.83 per share on April 7, 2026.On April 14, 2026, Lucid filed a current report on Form 8-K with the United States Securities and Exchange Commission ("U.S."), reporting, inter alia, its preliminary Q1 2026 financial results, including
More news about: Pomerantz LLP
Jul 23, 2026, 09:50 ET Association of Black Cardiologists to Celebrate Legacy and Leadership at 16th Annual Spirit of the Heart Awards
leaders whose innovation, compassion, and commitment will transform cardiovascular care and improve lives in communities across the country."Samin K. Sharma, MD, Chief of Clinical Cardiology, Director of the Cardiovascular Clinical Institute, and Anandi Lal Sharma Professor of Medicine at the
More news about: Association of Black Cardiologists
Jul 23, 2026, 09:25 ET V Šan-si proběhl mezinárodní dialog o světovém dědictví
zachování kulturního dědictví v kontextu globalizace a digitální transformace, na roli mládeže v předávání kulturního dědictví a na inovativní přístupy k přeshraničnímu šíření kultury.Provincie Šan-si se pyšní jedinečným kulturním dědictvím, které zahrnuje tři dochované dřevěné stavby z doby dynastie
More news about: China Daily
Jul 23, 2026, 09:23 ET Workday Adaptive Planning Achieves FedRAMP Moderate Authorization to Support Federal Workforce and Budget Planning
limited to, risks described in our filings with the Securities and Exchange Commission ("SEC"), including our most recent report on Form 10-Q or Form 10-K and other reports that we have filed and will file with the SEC from time to time, which could cause actual results to vary from expectations. Workday
More news about: Workday Inc.
Jul 23, 2026, 09:00 ET ProphetX and Players' Lounge Partner to Launch CFTC-Regulated Sports Prediction Markets to the Next Generation of Competitive Gamers
prediction markets, and Players' Lounge, the leading skill-based gaming platform where millions of gamers compete for real money on Madden NFL, NBA 2K, Call of Duty, Fortnite, and more, today announced a strategic partnership launching federally regulated sports prediction markets within the Players'
More news about: ProphetX
Jul 23, 2026, 09:00 ET Byli vyhlášeni vítězové třetího ročníku cen Stevie® za vynikající technologie
vstupenky jsou již v prodeji.„Gratulujeme všem vítězům třetího ročníku cen Stevie za vynikající technologie k jejich skvělým úspěchům," uvedla Maggie Millerová, ředitelka organizace Stevie Awards. „Inovace i nadále mění každé odvětví a letošní vítězové
More news about: Stevie Awards
Jul 23, 2026, 09:00 ET UST Retains Top Employer Honors from TEI, Earning Global Recognition for the Eighth Consecutive Year
415-9857 (US)+91-7899045194 (India)Merrick Laravea+1 (949) 416-6212Neha Misri+44-7341787926Roshni Das K+91 7736795557SomSekhar [email protected] Media
More news about: UST
Jul 23, 2026, 09:00 ET Hippo Rolls Out Claude and Other AI Tools Company-Wide, With 90% Employee Adoption in First Month
and uncertainties that could cause actual results to differ, please refer to the Risk Factors section of Hippo's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission.Media Contact: Mark Olson
More news about: Hippo Holdings Inc.
Jul 23, 2026, 08:56 ET FDA Clears Momentis Surgical's Anovo® System for Multiport Surgery, Making It the First Robotic Platform to Support Three Surgical Approaches
July 23, 2026 /PRNewswire/ -- Momentis Surgical today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the multiport configuration of the Anovo® Surgical System, expanding the versatility of the company's flexible robotic surgery platform.
More news about: Momentis Surgical
Jul 23, 2026, 08:47 ET Carrier Accelerates Intelligent Building Strategy with Acquisition of 75F
identifying factors that may cause actual results to vary materially from those stated in forward-looking statements, see Carrier's reports on Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission from time to time. Any forward-looking statement speaks only as of the
More news about: Carrier Global Corporation
Jul 23, 2026, 08:47 ET Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8013, an Antibody Drug Conjugate Targeting CD25 for the Treatment of Advanced Solid Tumors
INTRITM (golimumab) in US and GOTENFIA® (golimumab) in EU, TOFIDENCE® (tocilizumab) in the US, and AVZIVI® (bevacizumab-tnjn) in the US and in EU, a/k/a POBEVCY® in China. In addition, the company has more than 20 promising candidates in clinical trials, focusing on immuno-oncology in the post-PD-1 era
More news about: Bio-Thera Solutions, Ltd
Jul 23, 2026, 08:45 ET Autonomous Defense Technologies Set to Ignite a Nearly $200 Billion Global Market
those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking
More news about: Market News Updates
Jul 23, 2026, 08:31 ET LightPath Technologies Signs Definitive Agreement to Divest China Operations
factors detailed by the Company in its public filings with the Securities and Exchange Commission (the "SEC"), including its Annual Report on Form 10-K and other filings with the SEC. Should one or more of these risks, uncertainties, or facts materialize, or should underlying assumptions prove incorrect,
More news about: LightPath Technologies
Jul 23, 2026, 08:30 ET TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma
body of Phase 3 evidence evaluating the survival outcomes associated with the early use of immunotherapy doublets in the treatment journey," said Ajay K. Nooka, M.D., M.P.H., F.A.C.P., Director, Myeloma Program, Department of Hematology and Medical Oncology, Emory University School of Medicine.*
More news about: Johnson & Johnson
Jul 23, 2026, 08:30 ET The Sky Is No Longer the Limit: Drones as a Service Adoption Reaches Critical Mass Projected to Exceed $250 Billion Growth
those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking
More news about: Market News Updates
Jul 23, 2026, 08:30 ET Esquire Financial Holdings, Inc. Reports Second Quarter 2026 Results
risks detailed in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and other sections of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q as filed with the Securities and Exchange Commission. The forward-looking statements included in this press release
More news about: Esquire Financial Holdings, Inc.
Jul 23, 2026, 08:29 ET Citadel Securities otevírá pobočku v Amsterdamu
týmy inženýrů, obchodníků a analytiků využívají špičkový kvantitativní výzkum a rostoucí výkon výpočetní techniky, strojového učení a umělé inteligence k posílení našich analytických schopností a řešení nejzávažnějších výzev trhu i našich klientů.Společně utváříme budoucnost kapitálových trhů. Další
More news about: Citadel Securities
Jul 23, 2026, 08:15 ET Medgene offers first-ever cattle vaccine to address Theileria
prescription platform biologics have not been established. Medgene's products are prepared for use only by a veterinarian prescription.1Garcia K, Weakley M, Do T, Mir S. Current and Future Molecular Diagnostics of Tick-Borne Diseases in Cattle. Vet Sci. 2022 May 21;9(5):241. doi: 10.3390/vetsci9050241.
More news about: Medgene
Jul 23, 2026, 08:15 ET Norfolk Southern reports second quarter 2026 results
(vii) those pertaining to the Merger. These and other important factors, including those discussed under "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 9, 2026, may cause actual results, performance, or achievements to differ materially
More news about: Norfolk Southern Corporation
Jul 23, 2026, 08:01 ET Passage Preparation Wins 2026 CODiE Award for Best Professional Learning Platform
https://codieawards.com/winners.About K12 Coalition K12 Coalition is a collective of specialized education products and services with a common mission to provide a great education for every student in every classroom every day. The company offers deep expertise in solving five macro K-12 education challenges:
More news about: K12 Coalition
Jul 23, 2026, 08:00 ET NEST commits $200,000 to Saint Joseph's University to launch The Hawk's NEST: Building the Future of IFM and Skilled Trades Intelligence
faculty, and industry leaders to solve real-world challenges," said Rob Almond Jr., CEO of NEST and a 2024 inductee into Saint Joseph's University's Erivan K. Haub School of Business Hall of Fame. "The Hawk's NEST will allow students and researchers to work alongside our team to develop better tools, stronger
More news about: NEST
Jul 23, 2026, 08:00 ET California's Largest College of Education Unveils Framework for AI as a Companion to Teaching and Learning
California, the framework is designed to serve as a model for AI integration across NU's broader portfolio of academic programs and the broader field of K-12 and college instructors and instructional designers.
More news about: National University
Jul 23, 2026, 08:00 ET Precision Diabetes and Nagase Diagnostics Announce Exclusive U.S. Commercialization Partnership for Lucica® Glycated Albumin-L, the Only FDA-Cleared Assay Specifically Measured Glycated Albumin in the United States
today announced an exclusive U.S. commercialization partnership for the Lucica®GlycatedAlbumin(GA)-Lassay (510(k) No. K170147), the only assay with U.S. Food and Drug Administration (FDA) 510(k) clearance in the United States that is specifically intended to measure glycated albumin.
More news about: Precision Diabetes, Inc.
Jul 23, 2026, 08:00 ET Encompass Health increases and declares dividend on common stock
identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10‑K for the year ended December 31, 2025, and Form 10-Q for the quarter ended Mar. 31, 2026.Media contact:Polly
More news about: Encompass Health Corp.